LUNG 2022 PODCAST
We invite you to listen to our exclusive podcasts with Dr. Louis-Philippe Boulet sponsored by Sanofi-Genzyme:
Podcast Series Introduction – Dr. Andrew McIvor
Dr. Louis Philippe-Boulet – Type 2 Biomarkers in Severe Asthma: Focus on FeNO (English)
Dr. Louis Philippe-Boulet - Type 2 Biomarkers in Severe Asthma: Focus on FeNO (French)
CASE STUDY #1 – Dr. Louis Philippe-Boulet
CASE STUDY #2 – Dr. Louis Philippe-Boulet
Dr. Ronald Grossman - Management of Severe Asthma in Canada
CASE STUDY #3 – Dr. Ronald Grossman
As the specialty care global business unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world. For more information, visit Sanofi.ca or follow us on Twitter @SanofiCanada
Linkedin: https://www.linkedin.com/company/sanofi/
Twitter: @sanoficanada
Youtube: https://www.youtube.com/user/sanoficanada
Company website: https://www.sanofi.ca/
Facebook: https://www.facebook.com/SanofiGenzyme
ADDITIONAL RESOURCES:
Advent Program
WWW.ADVENTPROGRAM.COM
Agenda
Add to Calendar
Questions?
S & L Solutions
Phone: 647-462-1138
Email: info@slsolutionsevents.ca